Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 22nd Century Group Inc XXII

Consumer Defensive Tobacco
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco... see more

Recent & Breaking News (NDAQ:XXII)

22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business

GlobeNewswire May 23, 2022

22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform

GlobeNewswire May 18, 2022

22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company

GlobeNewswire May 13, 2022

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022

GlobeNewswire May 5, 2022

22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA's Proposed Ban on Menthol Cigarettes

GlobeNewswire April 29, 2022

22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders

GlobeNewswire April 28, 2022

22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner's Virtual Spring Consumer Cannabis Conference

GlobeNewswire April 27, 2022

22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022

GlobeNewswire April 14, 2022

First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland

GlobeNewswire April 13, 2022

22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer

GlobeNewswire April 11, 2022

FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That 'Helps You Smoke Less' Obtains Illinois Tobacco Product Listing

GlobeNewswire March 28, 2022

22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15

GlobeNewswire March 9, 2022

22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021

GlobeNewswire March 1, 2022

22nd Century Group Announces South Korea as First VLN® International Market

GlobeNewswire February 28, 2022

22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes

GlobeNewswire February 25, 2022

22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation

GlobeNewswire February 23, 2022

22nd Century Secures USDA Organic Certification for Needle Rock Farms

GlobeNewswire February 10, 2022

22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022

GlobeNewswire February 3, 2022

22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes

GlobeNewswire February 1, 2022

22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale

GlobeNewswire January 26, 2022